Cindy Cavelier

569 total citations
6 papers, 418 citations indexed

About

Cindy Cavelier is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Cindy Cavelier has authored 6 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Hematology and 2 papers in Oncology. Recurrent topics in Cindy Cavelier's work include Acute Myeloid Leukemia Research (4 papers), DNA Repair Mechanisms (3 papers) and Acute Lymphoblastic Leukemia research (2 papers). Cindy Cavelier is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), DNA Repair Mechanisms (3 papers) and Acute Lymphoblastic Leukemia research (2 papers). Cindy Cavelier collaborates with scholars based in France and United States. Cindy Cavelier's co-authors include Christian Récher, Véronique Mansat‐De Mas, Éric Delabesse, Cezary Swider, Kathleen M. Murphy, Anthony Secreto, Robin Perry, Martin Carroll, Jean‐Emmanuel Sarry and Gwenn Danet-Desnoyers and has published in prestigious journals such as Journal of Clinical Investigation, Cancer Research and Oncogene.

In The Last Decade

Cindy Cavelier

6 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cindy Cavelier France	6	256	238	123	90	72	6	418
Annet Z. Brouwers-Vos Netherlands	12	235 0.9×	328 1.4×	57 0.5×	73 0.8×	101 1.4×	17	485
René Marke Netherlands	4	289 1.1×	271 1.1×	94 0.8×	83 0.9×	98 1.4×	8	481
Monique Terwijn Netherlands	8	313 1.2×	138 0.6×	109 0.9×	120 1.3×	57 0.8×	16	412
Fedor Kryukov Czechia	11	200 0.8×	219 0.9×	68 0.6×	35 0.4×	103 1.4×	29	329
Virginia Giuliani Italy	3	92 0.4×	315 1.3×	149 1.2×	118 1.3×	71 1.0×	4	423
Vaia Stavropoulou Switzerland	9	212 0.8×	269 1.1×	125 1.0×	76 0.8×	57 0.8×	18	417
I‐Jun Lau United Kingdom	6	132 0.5×	276 1.2×	79 0.6×	32 0.4×	36 0.5×	7	354
Laura M. Kettyle United Kingdom	9	240 0.9×	277 1.2×	32 0.3×	146 1.6×	41 0.6×	17	433
Sue Colman United Kingdom	5	191 0.7×	149 0.6×	111 0.9×	36 0.4×	75 1.0×	6	395
Larisa Balaian United States	10	155 0.6×	406 1.7×	67 0.5×	100 1.1×	101 1.4×	18	507

Countries citing papers authored by Cindy Cavelier

Since Specialization

Citations

This map shows the geographic impact of Cindy Cavelier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cindy Cavelier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cindy Cavelier more than expected).

Fields of papers citing papers by Cindy Cavelier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cindy Cavelier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cindy Cavelier. The network helps show where Cindy Cavelier may publish in the future.

Co-authorship network of co-authors of Cindy Cavelier

This figure shows the co-authorship network connecting the top 25 collaborators of Cindy Cavelier. A scholar is included among the top collaborators of Cindy Cavelier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cindy Cavelier. Cindy Cavelier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

LaRochelle, Olivier, Sarah Bertoli, François Vergez, et al.. (2011). Do AML patients with DNMT3A exon 23 mutations benefit from idarubicin as compared to daunorubicin? A single center experience. Oncotarget. 2(11). 850–861. 22 indexed citations

2.

Sarry, Jean‐Emmanuel, Kathleen M. Murphy, Robin Perry, et al.. (2010). Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rγc-deficient mice. Journal of Clinical Investigation. 121(1). 384–395. 280 indexed citations

3.

Diot, Alan, Marlène Daloyau, Laetitia Pelloquin, et al.. (2010). Processing of the dynamin Msp1p in S. pombe reveals an evolutionary switch between its orthologs Mgm1p in S. cerevisiae and OPA1 in mammals. FEBS Letters. 584(14). 3153–3157. 12 indexed citations

4.

Cavelier, Cindy, Christine Didier, Naïs Prade, et al.. (2009). Constitutive Activation of the DNA Damage Signaling Pathway in Acute Myeloid Leukemia with Complex Karyotype: Potential Importance for Checkpoint Targeting Therapy. Cancer Research. 69(22). 8652–8661. 57 indexed citations

5.

Didier, Christine, Cindy Cavelier, Muriel Quaranta, et al.. (2008). G2/M checkpoint stringency is a key parameter in the sensitivity of AML cells to genotoxic stress. Oncogene. 27(27). 3811–3820. 27 indexed citations

6.

Didier, Christine, Cindy Cavelier, Muriel Quaranta, Cécile Demur, & Bernard Ducommun. (2008). Evaluation of Polo-like Kinase 1 inhibition on the G2/M checkpoint in Acute Myelocytic Leukaemia. European Journal of Pharmacology. 591(1-3). 102–105. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact